4.465

0.11% 0.005

Treace Medical Concepts Inc (TMCI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$4.46

Aprire:

$4.46

Volume 24 ore:

13,452

Relative Volume:

0.02

Capitalizzazione di mercato:

$290.38M

Reddito:

$207.32M

Utile/perdita netta:

$-61.04M

Rapporto P/E:

-4.6622

EPS:

-0.9577

Flusso di cassa netto:

$-25.97M

1 W Prestazione:

-6.78%

1M Prestazione:

+5.56%

6M Prestazione:

+136.24%

1 anno Prestazione:

-38.50%

Intervallo 1D:

$4.425

$4.49

Intervallo di 1 settimana:

$4.30

$4.75

Portata 52W:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Nome

Treace Medical Concepts Inc

Settore

Healthcare (1083)

Industria

Medical Devices (140)

Telefono

(904) 373-5940

Indirizzo

100 PALMETTO PARK PLACE, PONTE VEDRA

Dipendente

450

Cinguettio

Prossima data di guadagno

2026-08-07

Ultimi documenti SEC

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMCI Treace Medical Concepts Inc	4.465	296.56M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	114.68	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.90	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.36	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.62	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.50	53.19B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-07	Downgrade	BTIG Research	Buy → Neutral
2025-11-07	Downgrade	JP Morgan	Neutral → Underweight
2025-02-04	Aggiornamento	BTIG Research	Neutral → Buy
2024-12-31	Iniziato	Lake Street	Buy
2024-12-17	Ripresa	JP Morgan	Neutral
2024-05-16	Downgrade	UBS	Buy → Neutral
2024-05-08	Downgrade	BTIG Research	Buy → Neutral
2024-05-08	Downgrade	JP Morgan	Overweight → Neutral
2024-05-08	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-05-08	Downgrade	Stifel	Buy → Hold
2024-05-08	Downgrade	Truist	Buy → Hold
2023-09-29	Iniziato	UBS	Buy
2023-05-01	Iniziato	Truist	Buy
2023-04-11	Iniziato	Stephens	Equal-Weight
2022-05-12	Iniziato	BTIG Research	Buy
2022-01-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-05-18	Iniziato	JP Morgan	Overweight
2021-05-18	Iniziato	Morgan Stanley	Equal-Weight
2021-05-18	Iniziato	SVB Leerink	Outperform
2021-05-18	Iniziato	Stifel	Buy

Mostra tutto

Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie

Aug 19, 2026

TMCI senior director charged with insider trading in U.S. - Peoples Gazette Nigeria

Aug 19, 2026

Aug 18, 2026

Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi - The National Law Review

Aug 18, 2026

Treace Medical Concepts Earnings Call Signals Cautious Rebound - TipRanks

Aug 18, 2026

Aug 17, 2026

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC - MarketBeat

Aug 17, 2026

Aug 15, 2026

TMCI Q2 2026 Earnings: EPS Beat Drives 6.2% Stock Uptick as Losses NarrowProfit Warning Alert - Vinanet

Aug 15, 2026

Aug 14, 2026

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake - Stock Titan

Aug 14, 2026

Aug 12, 2026

Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - simplywall.st

Aug 12, 2026

Aug 11, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts - marketbeat.com

Aug 11, 2026

Aug 10, 2026

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial - MarketBeat

Aug 10, 2026

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating - marketscreener.com

Aug 10, 2026

Aug 09, 2026

Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall - Sahm

Aug 09, 2026

Aug 08, 2026

Treace Medical Concepts: Q2 Earnings Snapshot - theheraldreview.com

Aug 08, 2026

Aug 07, 2026

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Aug 07, 2026

Form 8K Treace Medical Concepts Inc For: 7 August By Investing.com - Investing.com Nigeria

Aug 07, 2026

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026